Sulfhydryl compound levels are associated with ATO-induced side effects in acute promyelocytic leukemia patients

Meijuan Suia Central Laboratory of The First Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China;b Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of ChinaView further author information

Hong Weic Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of ChinaView further author information

Xiaohan Shenc Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of ChinaView further author information

Keke Gaoc Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of ChinaView further author information

Qian Zhangc Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information

Zhuo Zhanga Central Laboratory of The First Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information

Sulfhydryl compound levels are associated with ATO-induced side effects in acute promyelocytic leukemia patients

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Sulfhydryl compound levels are associated with ATO-induced side effects in acute promyelocytic leukemia patients

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date